Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Acq. announced
|
|
Imunon, Inc. (CLSN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/29/2015 |
8-K/A
| Financial Statements and Exhibits |
| 08/25/2014 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Anglin, Reichmann, Snellgrove & Armstrong P.C",
"Financial statements of Egen, Inc. as of and for the year ended June 30, 2013 and for the period from March 2, 2002 (date of inception) to June 30, 2013, together with the independent auditors’ report",
"Financial statements of Egen, Inc. as of and for the year ended June 30, 2012, together with the independent auditors’ report",
"Unaudited condensed financial statements of Egen, Inc. as of March 31, 2014 and 2013 and for the three and nine month periods ended March 31, 2014 and 2013",
"Unaudited Pro Forma Condensed Combined Financial Statements" |
|
| 02/20/2009 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 04/13/2007 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 01/26/2007 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|